BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2451246)

  • 1. Enhancement of acute allergic inflammation by indomethacin is reversed by prostaglandin E2: apparent correlation with in vivo modulation of mediator release.
    Raud J; Dahlén SE; Sydbom A; Lindbom L; Hedqvist P
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2315-9. PubMed ID: 2451246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravital microscopic studies on acute mast cell-dependent inflammation.
    Raud J
    Acta Physiol Scand Suppl; 1989; 578():1-58. PubMed ID: 2471389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation.
    Raud J
    Br J Pharmacol; 1990 Mar; 99(3):449-54. PubMed ID: 2158843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 prevents diclofenac-induced enhancement of histamine release and inflammation evoked by in vivo challenge with compound 48/80 in the hamster cheek pouch.
    Raud J; Sydbom A; Dahlén SE; Hedqvist P
    Agents Actions; 1989 Aug; 28(1-2):108-14. PubMed ID: 2476919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tenoxicam and indomethacin on the release of histamine, prostaglandin E2 and leukotrienes from various cells.
    König W; Brom J; Schönfeld W; Knöller J; Stüning M
    Arzneimittelforschung; 1987 Mar; 37(3):296-9. PubMed ID: 2439092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular actions of histamine: synergism with leukotriene B4 and role in allergic leucocyte recruitment.
    Thorlacius H; Lindbom L; Hedqvist P; Raud J
    Clin Exp Allergy; 1997 Apr; 27(4):445-51. PubMed ID: 9146939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 reverses indomethacin-induced enhancement of acute allergic inflammation in the hamster cheek pouch.
    Raud J; Dahlén SE; Hedqvist P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():908-12. PubMed ID: 2960204
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of the inhibitory action of cyclooxygenase inhibitors on leukocyte infiltration: involvement of endogenous histamine.
    Hirasawa N; Ohuchi K; Watanabe M; Tsurufuji S
    Eur J Pharmacol; 1987 Dec; 144(3):267-75. PubMed ID: 2894313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase inhibitors promote the leukotriene C4 induced release of beta-glucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses.
    Schenkelaars EJ; Bonta IL
    Int J Immunopharmacol; 1986; 8(3):305-11. PubMed ID: 3089952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes.
    Levine JD; Lau W; Kwiat G; Goetzl EJ
    Science; 1984 Aug; 225(4663):743-5. PubMed ID: 6087456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of synthetic leukotrienes on local blood flow and vascular permeability in porcine skin.
    Chan CC; Ford-Hutchinson A
    J Invest Dermatol; 1985 Feb; 84(2):154-7. PubMed ID: 2981933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of leukotriene B4-mediated inflammatory response by the adenosine antagonist, 8-phenyl theophylline.
    Rosengren S; Arfors KE; Proctor KG
    Int J Microcirc Clin Exp; 1991 Nov; 10(4):345-57. PubMed ID: 1663916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intravital microscopic model for mast cell-dependent inflammation in the hamster cheek pouch.
    Raud J; Dahlén SE; Smedegård G; Hedqvist P
    Acta Physiol Scand; 1989 Feb; 135(2):95-105. PubMed ID: 2493712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular permeability responses and the role of prostaglandin E2 in an experimental allergic inflammation of air pouch type in rats.
    Hirasawa N; Ohuchi K; Sugio K; Tsurufuji S; Watanabe M; Yoshino S
    Br J Pharmacol; 1986 Apr; 87(4):751-6. PubMed ID: 3085758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of leukotriene C4 and prostaglandin E2 on the rat mesentery in vitro and in vivo.
    Gulati N; Philpot ME; Gulati OP; Malmsten C; Huggel H
    Prostaglandins Leukot Med; 1983 Mar; 10(3):257-68. PubMed ID: 6573690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotrienes B4 and C4 have distinct microcirculatory actions in vivo.
    Björk J; Dahlén SE; Hedqvist P; Arfors KE
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():1-6. PubMed ID: 6303078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhibitors of prostaglandin synthesis and prostaglandins E2 and F2alpha on the immunologic release of mediators of inflammation from actively sensitized guinea-pig lung.
    Hitchcock M
    J Pharmacol Exp Ther; 1978 Nov; 207(2):630-40. PubMed ID: 712645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual action of prostaglandin E2 in allergic inflammation.
    Hedqvist P; Raud J; Dahlén SE
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():539-42. PubMed ID: 2526534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin.
    Baud L; Perez J; Denis M; Ardaillou R
    J Immunol; 1987 Feb; 138(4):1190-5. PubMed ID: 3027173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.